Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 2026 entries
View as:

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT05595642 Org: User:
Start: 12/29/22 End: 03/11/27 Due: 03/11/28

A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis.

Phase: N/A Priority: Normal
NCT ID: NCT01988012 Org: User:
Start: 01/31/14 End: 07/31/15 Due: 07/31/16

EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02648035 Org: User:
Start: 09/22/16 End: 12/20/18 Due: 12/20/19

A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

Phase: N/A Priority: Normal
NCT ID: NCT03280550 Org: User:
Start: 11/15/17 End: 03/11/19 Due: 03/11/20

Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02467907 Org: User:
Start: 07/28/15 End: 01/15/19 Due: 01/15/20

A Study of Trastuzumab Subcutaneous in Participants With Human Epidermal Growth Factor Receptor-2 (HER2) Positive Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01959386 Org: User:
Start: 11/07/13 End: 01/31/19 Due: 01/31/20

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

Phase: N/A Priority: Normal
NCT ID: NCT04998851 Org: User:
Start: 09/16/21 End: 01/13/25 Due: 01/13/26

Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib

Phase: N/A Priority: Normal
NCT ID: NCT02621047 Org: User:
Start: 12/04/15 End: 12/08/16 Due: 12/08/17

A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01494688 Org: User:
Start: 12/20/11 End: 02/07/18 Due: 02/07/19

Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen

Phase: N/A Priority: Normal
NCT ID: NCT02419742 Org: User:
Start: 08/18/15 End: 06/24/21 Due: 06/24/22

A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01043029 Org: User:
Start: 05/31/10 End: 07/31/12 Due: 07/31/13

GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT00105079 Org: User:
Start: 04/30/05 End: 07/31/08 Due: 07/31/09

A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)

Phase: N/A Priority: Normal
NCT ID: NCT01156961 Org: User:
Start: 10/31/10 End: 12/31/12 Due: 12/31/13

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT04615325 Org: User:
Start: 12/08/20 End: 01/04/23 Due: 01/04/24

A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA.

Phase: N/A Priority: Normal
NCT ID: NCT00661388 Org: User:
Start: 08/31/08 End: 12/31/10 Due: 12/31/11

A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00674986 Org: User:
Start: 03/31/08 End: 02/28/10 Due: 02/28/11

A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.

Phase: N/A Priority: Normal
NCT ID: NCT00048048 Org: User:
Start: 03/31/02 End: 11/30/04 Due: 11/30/05

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.

Phase: N/A Priority: Normal
NCT ID: NCT00717457 Org: User:
Start: 07/31/08 End: 03/31/11 Due: 03/31/12

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants

Phase: N/A Priority: Normal
NCT ID: NCT02952924 Org: User:
Start: 12/14/16 End: 03/16/22 Due: 03/16/23

A Study of MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL)

Phase: N/A Priority: Normal
NCT ID: NCT01356589 Org: User:
Start: 09/30/10 End: 07/31/12 Due: 07/31/13

A Study of RO4917523 in Patients With Fragile X Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01517698 Org: User:
Start: 05/31/12 End: 04/30/14 Due: 04/30/15

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

Phase: N/A Priority: Normal
NCT ID: NCT00377234 Org: User:
Start: 05/31/06 End: 08/31/08 Due: 08/31/09

An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study

Phase: N/A Priority: Normal
NCT ID: NCT01588184 Org: User:
Start: 07/13/12 End: 09/27/19 Due: 09/27/20

A Study of Monthly Subcutaneous Continuous Erythropoietin Receptor Activator (CERA) in Predialysis Participants With Chronic Renal Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00773968 Org: User:
Start: 09/30/08 End: 03/31/10 Due: 03/31/11

A Study to Evaluate the Efficacy and Safety of Pertuzumab + Trastuzumab + Docetaxel Versus Placebo + Trastuzumab + Docetaxel in Previously Untreated Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02896855 Org: User:
Start: 09/13/16 End: 01/22/21 Due: 01/22/22